1. Home
  2. SWZ vs DRIO Comparison

SWZ vs DRIO Comparison

Compare SWZ & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Swiss Helvetia Fund Inc. (The)

SWZ

Swiss Helvetia Fund Inc. (The)

N/A

Current Price

$5.85

Market Cap

77.3M

Sector

Finance

ML Signal

N/A

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$6.66

Market Cap

70.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWZ
DRIO
Founded
1986
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.3M
70.6M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
SWZ
DRIO
Price
$5.85
$6.66
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $35.00
AVG Volume (30 Days)
★ 26.8K
15.2K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
★ 6.59%
N/A
EPS Growth
N/A
★ 1559.02
EPS
N/A
★ 1.75
Revenue
N/A
★ $7,394,000.00
Revenue This Year
N/A
$20.27
Revenue Next Year
N/A
$47.58
P/E Ratio
★ N/A
$3.87
Revenue Growth
N/A
★ 43.02
52 Week Low
$5.83
$5.84
52 Week High
$6.31
$17.74

Technical Indicators

Market Signals
Indicator
SWZ
DRIO
Relative Strength Index (RSI) 27.84 45.02
Support Level N/A $6.13
Resistance Level $6.00 $8.10
Average True Range (ATR) 0.04 0.27
MACD -0.01 -0.01
Stochastic Oscillator 5.26 29.86

Price Performance

Historical Comparison
SWZ
DRIO

About SWZ Swiss Helvetia Fund Inc. (The)

Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. It actively manages investment solutions spanning public and private markets, wealth management, and Solutions.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: